Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 1, 2014, Pages 37-45

  Brown, Adam J ^a,b   McCormick, Liam M ^a   Braganza, Denise M ^a   Bennett, Martin R ^b   Hoole, Stephen P ^a   West, Nick E J ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

bioabsorbable; imaging; optical coherence tomography; percutaneous coronary intervention; stent

Indexed keywords

ADULT; ARTERY DILATATION; ARTICLE; BIORESORBABLE SCAFFOLD; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FIBROCALCIFIC PLAQUE; HUMAN; IN VIVO STUDY; MALE; MINIMUM SCAFFOLD DIAMETER; OPTICAL COHERENCE TOMOGRAPHY; PHYSICAL PHENOMENA; SCAFFOLD CROSS SECTIONAL AREA; SCAFFOLD EXPANSION; STENT MALAPPOSITION; VASCULAR DISEASE; BIODEGRADABLE IMPLANT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG ELUTING STENT; MIDDLE AGED; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS; TISSUE SCAFFOLD; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84903550786     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25378     Document Type: Article

References (29)

1. Serruys PW, Onuma Y, Ormiston JA, De Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hébert K, Rapoza R, Garcia-Garcia HM,. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes. Circulation 2010; 122: 2301-2312.
2. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D,. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009; 373: 897-910.
3. Sarno G, Bruining N, Onuma Y, Garg S, Brugaletta S, De Winter S, Regar E, Thuesen L, Dudek D, Veldhof S, Dorange C, Garcia-Garcia HM, Ormiston JA, Serruys PW,. Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: A patient level insight into the ABSORB A clinical trial. Int J Cardiovasc Imaging 2012; 28: 51-58.
4. Garg S, Serruys PW,. Coronary stents: Looking forward. J Am Coll Cardiol 2010; 56: S43-78.
5. Onuma Y, Serruys PW,. Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011; 123: 779-797.
6. Ormiston JA, De Vroey F, Serruys PW, Webster MWI,. Bioresorbable polymeric vascular scaffolds: A cautionary tale. Circ Cardiovasc Interv 2011; 4: 535-538.
7. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG, POST Registry Investigators. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002; 23: 124-132.
8. Cook S, Eshtehardi P, Kalesan B, Räber L, Wenaweser P, Togni M, Moschovitis A, Vogel R, Seiler C, Eberli FR, Lüscher T, Meier B, Juni P, Windecker S,. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J 2012; 33: 1334-1343.
9. Fujii K, Carlier SG, Mintz GS, Yang Y-M, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB,. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-998.
10. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW,. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088.
11. Jaguszewski M, Wyss C, Alibegovic J, Lüscher TF, Templin C,. Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome. Eur Heart J 2013; 34: 2046.
12. Bouma BE, Tearney GJ, Yabushita H, Shishkov M, Kauffman CR, DeJoseph Gauthier D, MacNeill BD, Houser SL, Aretz HT, Halpern EF, Jang I-K,. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 2003; 89: 317-320.
13. Brown AJ, McCormick LM, Hoole SP, West NEJ,. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold. JACC Cardiovasc Interv 2013; 6: e41-e42.
14. Gutiérrez-Chico JL, Gijsen F, Regar E, Wentzel J, De Bruyne B, Thuesen L, Ormiston J, McClean, Windecker S, Chevalier B, Dudek D, Whitbourn R, Brugaletta S, Onuma Y, Serruys PW,. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: Evidence in vivo about the abluminal healing process. JACC Cardiovasc Interv 2012; 5: 428-435.
15. Fujino Y, Bezerra HG, Attizzani GF, Wang W, Yamamoto H, Chamié D, Kanaya T, Mehanna E, Tahara S, Nakamura S, Costa MA,. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound. Catheter Cardiovasc Interv 2013; 82: E173-E183.
16. Gõmez-Lara J, Radu M, Brugaletta S, Farooq V, Diletti R, Onuma Y, Windecker S, Thuesen L, McClean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW,. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc Interv 2011; 4: 992-1001.
17. Jang I-K, Bouma BE, Kang D-H, Park S-J, Park S-W, Seung K-B, Choi K-B, Shishkov M, Schlendorf K, Pomerantsev E, Houser SL, Aretz HT, Tearney GJ,. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: Comparison with intravascular ultrasound. J Am Coll Cardiol 2002; 39: 604-609.
18. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho J-M, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Dudeck D, Falk E, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Garcia H, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CCS, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel M-A, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Räber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PWJC, Shimada K, Shinke T, Shite J, Siegel E, Sonoda S, Sonada S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T, Troels T, Uemura S, Ughi GJ, van Beusekom HMM, van der Steen AFW, van Es G-A, van Es G-A, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G, International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT). Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: A report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012; 1058-1072.
19. Brugaletta S, Gõmez-Lara J, Diletti R, Farooq V, van Geuns RJ, De Bruyne B, Dudek D, Garcia-Garcia HM, Ormiston JA, Serruys PW,. Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 2012; 79: 219-228.
20. Sheehy A, Gutiérrez-Chico JL, Diletti R, Oberhauser JP, Glauser T, Harrington J, Kossuth MB, Rapoza RJ, Onuma Y, Serruys PW., In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis. EuroIntervention 2012; 7: 1227-1235.
21. Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, Ishikawa M, Kawai T, Takagi Y, Ishii J, Prati F, Serruys PW,. The fate of incomplete stent apposition with drug-eluting stents: An optical coherence tomography-based natural history study. Eur Heart J 2010; 31: 1470-1476.
22. de Ribamar Costa J, Mintz GS, Carlier SG, Costa RA, Fujii K, Sano K, Kimura M, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB,. Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol 2005; 96: 74-78.
23. de Ribamar Costa J, Mintz GS, Carlier SG, Fujii K, Sano K, Kimura M, Tanaka K, Costa RA, Lui J, Na Y, Castellanos C, Biro S, Moussa I, Stone GW, Moses JW, Leon MB,. Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 2007; 153: 297-303.
24. Romagnoli E, Sangiorgi GM, Cosgrave J, Guillet E, Colombo A,. Drug-eluting stenting: The case for post-dilation. JACC Cardiovasc Interv 2008; 1: 22-31.
25. Guagliumi G, Bezerra HG, Sirbu V, Ikejima H, Musumeci G, Biondi-Zoccai G, Lortkipanidze N, Fiocca L, Capodanno D, Wang W, Tahara S, Vassileva A, Matiashvili A, Valsecchi O, Costa MA,. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv 2012; 5: 30-38.
26. Lindsay AC, Paulo M, Kadriye K, Tejeiro R, Alegría-Barrero E, Chan PH, Foin N, Syrseloudis D, Di Mario C,. Predictors of stent strut malapposition in calcified vessels using frequency-domain optical coherence tomography. J Invasive Cardiol 2013; 25: 429-434.
27. Albrecht D, Kaspers S, Füssl R, Höpp HW, Sechtem U,. Coronary plaque morphology affects stent deployment: Assessment by intracoronary ultrasound. Cathet Cardiovasc Diagn 1996; 38: 229-235.
28. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, De Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA,. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 2011; 58: 1578-1588.
29. Manfrini O, Mont E, Leone O, Arbustini E, Eusebi V, Virmani R, Bugiardini R,. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 2006; 98: 156-159.